Lilly completes biopharma acquisitions
Eli Lilly and Company has completed acquisition of two biopharmaceutical companies – Versanis Bio and Sigilon Therapeutics - and their lead assets focused on obesity and diabetes. Lilly announced... -Today at 06:31 pm- MarketScreener
Source: marketscreener.com